Russell Investments Group, Ltd. Esperion Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 489 shares of ESPR stock, worth $1,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489

Holding current value

$1,139

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.61 - $2.73 $787 - $1,334	489 New	489 $0
Q1 2024 May 08, 2024	SELL	$2.02 - $3.02 $664 - $993	-329 Reduced 0.39%	84,367 $226,000
Q4 2023 Feb 05, 2024	SELL	$0.73 - $3.08 $1,195 - $5,045	-1,638 Reduced 1.9%	84,696 $253,000
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $69,200 - $129,030	72,084 Added 505.85%	86,334 $84,000
Q2 2023 Aug 10, 2023	SELL	$1.2 - $1.76 $8,746 - $12,828	-7,289 Reduced 33.84%	14,250 $19,000
Q1 2023 May 09, 2023	BUY	$1.46 - $7.3 $6,259 - $31,295	4,287 Added 24.85%	21,539 $34,000
Q4 2022 Feb 08, 2023	BUY	$5.09 - $8.5 $87,812 - $146,642	17,252 New	17,252 $107,000
Q4 2021 Jan 21, 2022	SELL	$4.81 - $11.92 $454,569 - $1.13 Million	-94,505 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$11.34 - $21.37 $1.07 Million - $2.02 Million	94,505 New	94,505 $1.14 Million
Q2 2021 Aug 04, 2021	SELL	$19.4 - $28.71 $612,361 - $906,231	-31,565 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$25.12 - $36.89 $313,974 - $461,088	-12,499 Reduced 28.37%	31,565 $884,000
Q4 2020 Feb 08, 2021	SELL	$24.2 - $35.76 $807,675 - $1.19 Million	-33,375 Reduced 43.1%	44,064 $1.15 Million
Q3 2020 Nov 09, 2020	BUY	$31.18 - $52.71 $823,494 - $1.39 Million	26,411 Added 51.76%	77,439 $2.88 Million
Q2 2020 Aug 05, 2020	SELL	$30.04 - $51.31 $46,832 - $79,992	-1,559 Reduced 2.96%	51,028 $2.61 Million
Q1 2020 May 06, 2020	BUY	$27.44 - $73.84 $43,437 - $116,888	1,583 Added 3.1%	52,587 $1.66 Million
Q4 2019 Jan 29, 2020	BUY	$35.4 - $59.82 $744,886 - $1.26 Million	21,042 Added 70.23%	51,004 $3.04 Million
Q3 2019 Nov 01, 2019	BUY	$34.47 - $47.53 $1.01 Million - $1.39 Million	29,276 Added 4267.64%	29,962 $1.1 Million
Q2 2019 Aug 09, 2019	BUY	$40.1 - $52.33 $27,508 - $35,898	686 New	686 $32,000
Q1 2019 May 13, 2019	SELL	$40.11 - $53.57 $418,788 - $559,324	-10,441 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$36.99 - $59.11 $73,277 - $117,096	-1,981 Reduced 15.95%	10,441 $480,000
Q3 2018 Oct 26, 2018	BUY	$40.74 - $51.41 $433,595 - $547,156	10,643 Added 598.26%	12,422 $551,000
Q1 2018 May 11, 2018	SELL	$65.94 - $80.76 $43,850 - $53,705	-665 Reduced 27.21%	1,779 $129,000
Q4 2017 Feb 06, 2018	SELL	$43.47 - $67.43 $983,639 - $1.53 Million	-22,628 Reduced 90.25%	2,444 $165,000
Q3 2017 Nov 07, 2017	BUY	$43.8 - $52.77 $1.1 Million - $1.32 Million	25,072	25,072 $1.26 Million

Others Institutions Holding ESPR

# of Institutions

207

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Esperion Therapeutics, Inc. Transaction History